GINZA NOA CLINIC
Tokyo, Japan International Patient Support
Contact Us

What Emergency Support Should a Clinic Have?

A clinic should have a trained on-site team, checked emergency medicines and equipment, monitoring during treatment and recovery, a written emergency response and hospital-transfer plan, and clear after-hours instructions. The team must be able to recognize a serious reaction, start appropriate emergency care, and call an ambulance without delay. A phone number for a nearby hospital is not a complete plan.

A severe allergic reaction, called anaphylaxis, can develop quickly and become life-threatening Anaphylaxis. For vaccination services, the U.S. Centers for Disease Control and Prevention calls for immediate access to allergy treatment and airway equipment, and a plan to contact emergency medical services immediately after a severe acute reaction Adverse reactions.

What Emergency Support Should a Clinic Have?

The checklist below focuses on outpatient procedures, including cell collection, infusions, and injections offered by regenerative medicine clinics. Equipment, staffing, and monitoring should match the procedure, any anesthesia used, and your medical risks. U.S. guidance cited here is a reference, not a statement of Japanese legal requirements. Emergency preparedness also does not establish that a stem cell treatment is effective or appropriate. The FDA warns that unapproved regenerative medicine products have been associated with serious harm, including infections and unwanted immune reactions Important patient and consumer information about regenerative medicine therapies.

Who Should Be Ready to Respond

Before collection, infusion, or injection, ask who is responsible for your care and who will remain on site during the procedure and recovery. Confirm the clinician’s license, the staff’s resuscitation training, and who takes over if the usual lead is unavailable.

For office-based anesthesia specifically, the American Society of Anesthesiologists recommends that the anesthesiologist be physically present during the procedure and immediately available until discharge from anesthesia care. Personnel trained in advanced resuscitation should be immediately available until all patients have been discharged home Statement on office based anesthesia.

  • Someone is assigned to monitor you, rather than relying on you to notice and report every change.
  • Staff know who starts emergency care, calls the ambulance, brings equipment, and prepares the handover.
  • The team can explain its most recent emergency drill and how it checks staff readiness.
  • If you need language support, confirm how staff will communicate symptoms and urgent instructions during treatment, recovery, and after hours.

For care abroad, discuss the complication-management plan with both the treating clinician and your doctor at home. The CDC also advises requesting overseas medical records in English for subsequent care Medical tourism.

Who monitors me during treatment, and who leads the response if I develop breathing difficulty or collapse?

Emergency Medicines and Equipment

Ask the clinical team which items it keeps ready for your procedure, where they are stored, and how checks are documented. For office-based anesthesia, ASA guidance includes oxygen with a backup supply, suction, ventilation equipment, emergency drugs, a defibrillator, and difficult-airway equipment, with maintenance and testing according to manufacturers’ instructions Statement on office based anesthesia.

  • Breathing support: oxygen, suction, and equipment that trained staff can use to support breathing.
  • Monitoring: blood pressure and oxygen-level measurement, with heart and breathing monitoring appropriate to the procedure and anesthesia.
  • Resuscitation: an accessible, functional defibrillator and staff trained to use it.
  • Emergency medicines: treatment for severe allergy, plus medicines and supplies selected for the procedure’s other risks. CDC vaccination guidance specifically calls for epinephrine and airway equipment to be available for immediate use; it is not a complete equipment standard for cell procedures Adverse reactions.
  • Procedure-specific supplies: bleeding-control materials after tissue collection, and IV access and fluids when clinically indicated.

For fat collection under local anesthesia, ask how the team would respond to bleeding or a reaction to the anesthetic. For an infusion, ask how it would stop administration and manage a severe reaction. A general assurance that the clinic has an emergency kit does not answer either question.

Support Matched to Your Procedure

Check each stage in the treatment process separately. Collection, administration, and recovery may happen in different rooms or on different days.

Procedure Emergency support to ask about
Fat collection Who manages bleeding, anesthetic reactions, wound care, and recovery?
IV infusion Who monitors symptoms and vital signs, stops the infusion, and begins emergency care?
Joint or other injection How are fainting, bleeding, and suspected infection assessed and escalated?
Sedation or anesthesia, if used Who provides anesthesia, monitors breathing, manages airway problems, and supervises recovery?

If a procedure or your medical condition exceeds the facility’s capabilities, ask whether it should be performed elsewhere. ASA office-based anesthesia guidance recommends referring patients at undue risk to an appropriate facility Statement on office based anesthesia.

Monitoring Before You Leave

Before Treatment

Give the clinician your allergy history, current medicines, previous anesthesia reactions, and relevant heart, lung, bleeding, or infection problems. Ask how these change the monitoring and rescue plan. Information on indications and contraindications can help you prepare questions, but it cannot establish your individual eligibility.

During Treatment

Confirm who watches your vital signs and symptoms, whether monitoring is continuous or intermittent, and what triggers an escalation. If sedation is planned, ask specifically about breathing monitoring and airway rescue. The monitoring method should be selected by the responsible clinician for the anesthesia and procedure, not chosen from a generic checklist.

During Recovery

Ask for the planned observation period and the clinical criteria for discharge. In U.S. vaccination guidance, 80% of reported fainting episodes occur within 15 minutes of vaccination, and providers are advised to consider 15 minutes of observation to reduce injury from fainting Adverse reactions. These data are about vaccination, not cell therapy. They do not establish an adequate observation period after a cell infusion, tissue collection, or sedation.

Before leaving, obtain written warning signs, instructions for urgent versus routine help, and an after-hours contact with a backup if nobody answers. When assessing stem cell therapy safety in Japan, ask about the exact procedure and recovery arrangements, not just the treatment label.

What must be checked before I can leave, and where should I seek help if symptoms develop tonight?

A Written Response and Hospital-Transfer Plan

The plan should identify who starts emergency care, how an ambulance is called, and how care continues while transfer is arranged. ASA office-based anesthesia guidance recommends emergency simulations and a written protocol for safe, timely transfer to a prespecified facility when care beyond the office’s capabilities is needed Statement on office based anesthesia.

  • Receiving care: the intended hospital, its emergency capabilities, and what happens if it cannot accept the patient.
  • Transport: how emergency services are activated and who stays with the patient until handover.
  • Handover: the procedure, product details where available, symptoms, vital signs, medicines given, and clinician contact information.
  • Practical arrangements: estimated travel time, night and weekend arrangements, and how family members receive information.

Ask what transfer arrangements actually exist. A clinic naming a nearby hospital is not the same as that hospital agreeing to accept every emergency. Do not treat an estimated travel time as a guaranteed time to definitive care.

If you travel, establish who handles complications after you return home and how your records will reach that clinician. The medical travel planning guide can help organize those questions. Confirm who pays for additional care; CDC notes that some providers charge separately for follow-up Medical tourism.

Infection Prevention and Follow-Up

Infection prevention and emergency response are different tasks. WHO hand-hygiene guidance supports routine infection prevention in healthcare Hand hygiene. Separately, ask who evaluates fever, worsening wound symptoms, or suspected contamination after a procedure.

For cell procedures, ask how samples and products are identified and traced, and what happens if contamination is suspected. The FDA’s regenerative medicine warning lists cross-contamination and life-threatening bacterial infections among safety concerns for unapproved products Important patient and consumer information about regenerative medicine therapies. This warning does not quantify the risk for a particular Japanese clinic or product.

How to Check the Answers in Practice

For a pre-treatment consultation, use a concrete scenario: ask what the team would do if you developed sudden breathing difficulty during an infusion. Request the response sequence, the staff roles, the equipment location, and the transfer process. This is a discussion exercise, not a test you should perform on equipment or medicines yourself.

Ask for What to check
The monitoring and response roles Names or designated roles for the clinician, observer, emergency caller, and handover lead.
Evidence of equipment readiness How expiry dates, servicing, supplies, and defibrillator readiness are checked and documented.
The transfer plan The intended receiving facility, arrangements if it is unavailable, and the handover information.
The aftercare sheet Discharge criteria, warning signs, the after-hours contact, and what to do if that contact is unavailable.

A tour or a confident explanation cannot establish clinical competence. Use the answers to identify gaps, then discuss unresolved concerns with an independent clinician. When comparing clinics and hospitals in Japan, record the same questions for each facility rather than relying on impressions.

Red Flags Before You Consent

  • The clinic cannot identify the responsible clinician, describe its emergency equipment, or explain escalation and transfer.
  • Its only response to a serious reaction is to telephone a doctor who is off site.
  • Sedation is offered without a clear anesthesia, monitoring, rescue, and recovery plan.
  • There are no written aftercare instructions or no backup route for urgent help.
  • Staff dismiss complications, guarantee results, or use regulatory paperwork instead of explaining risks.

In Japan, submission of a regenerative medicine provision plan under the Act on the Safety of Regenerative Medicine is distinct from product approval. It does not by itself establish that a proposed treatment works Index. Approved treatments, investigational interventions, and private-clinic services should not be presented as interchangeable.

When Not to Wait for a Clinic Reply

A severe allergic reaction needs emergency help, not a routine callback Anaphylaxis. If you develop severe breathing difficulty, collapse, or other life-threatening symptoms, contact local emergency services rather than waiting for an inquiry form or after-hours message to be answered.

For an ambulance in Tokyo, dial 119. Shibuya City’s official guidance explains how to make the call and provide your location Dial119. Elsewhere, confirm the local emergency arrangements before treatment.

What to Confirm Before Booking

Get the responsible clinician, monitoring and recovery plan, emergency response arrangements, hospital-transfer route, and after-hours instructions in writing. Keep the treatment and product records needed for subsequent care. If important answers remain unclear, postpone the decision and ask your own doctor. This checklist is general patient information, not an individual medical assessment or a guarantee of safety.

Ask About Emergency Support

For non-urgent questions before booking. This contact page is not an emergency service.

References

  1. U.S. National Library of Medicine. MedlinePlus: Anaphylaxis.
  2. Centers for Disease Control and Prevention. Preventing and Managing Adverse Reactions. U.S. vaccination guidance.
  3. U.S. Food and Drug Administration. Important Patient and Consumer Information About Regenerative Medicine Therapies.
  4. American Society of Anesthesiologists. Statement on Office-Based Anesthesia.
  5. Centers for Disease Control and Prevention. Medical Tourism. CDC Yellow Book, 2026 edition.
  6. World Health Organization. Hand Hygiene.
  7. Ministry of Health, Labour and Welfare, Japan. Regenerative Medicine.
  8. Shibuya City, Tokyo. For Fire, Ambulance and Rescue Assistance: Dial 119.